🔬 Pharmidex at the SMR Women’s Health Meeting – June 17, 2025 🌸
June 17, 2025
We’re excited to share that Janette Robertson (Business Development Manager) and Professor Mo Alavijeh (Managing Director) will attend the SMR Women’s Health Meeting at Friends House, London.
They look forward to meeting attendees and discussing collaboration opportunities in drug discovery and development, especially in women’s health.
đź“… More info: https://www.smr.org.uk/Meetings/20250617/
🤝 Let’s connect in London!
#Pharmidex #WomensHealth #DrugDiscovery #CRO #SMR2025 #PharmaCollaborations
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: âś… Bitter-tasting APIs âś… Unpalatable excipients âś… The success of taste-masking strategies âś… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
